Merck and Pfizer Seek Approval for COVID-19 Antiviral Drugs
Merck and Pfizer have submitted Emergency Use Authorization (EUA) applications to the U.S. Food and Drug Administration (FDA) to authorize distribution of what would be the first antiviral drug specifically designed to treat COVID-19 disease.1 Merck/Ridgeback Biotherapeutics are seeking EUA approval for Molnupiravir (MK-4482/EIDD-2801), an investigational oral antiviral drug originally developed to treat influenza.2 Pfizer […]
Efficacy of Pfizer’s COVID Biologic Estimated at 33 Percent
A recent study soon to be published in the Journal of Medical Biochemistry found that Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19 significantly loses its efficacy within six months of the second shot. Researchers from the University of Verona in Italy and Cincinnati Children’s Hospital Medical Center in Ohio looked at 787 health […]
Pharmacies Give Wrong Doses of Pfizer COVID Biologic to Children
Several pharmacies, including Ted Pharmacy in Aldie, Virginia,1 recently gave young children an adult dose of the Pfizer/BioNTech experimental COVID BNT162b2 biologic rather than the reduced dose specially formulated for children give to 11 years old after the U.S. Centers for Disease Control and Prevention (CDC) expanded the recommendation for use of the Pfizer/BioNTech shot […]
FDA Asks Court to Delay Full Release of Documents on Pfizer COVID Biologic for 55 Years
In response to a Freedom of Information Act (FOIA) lawsuit filed on Sept. 16, 2021 against the U.S. Food and Drug Administration (FDA) by a medical transparency group of more than 30 physicians, professors and scientists from various universities in the United States, the FDA has asked a federal judge to delay the full release […]
Tennessee Man Dies Three Days After Getting Second Pfizer COVID Shot
A 36-year-old man in Madison County, Tennessee died unexpectedly on Sept. 25, 2021, three days after receiving the second dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19. Timothy Adam Hornsby was vaccinated on Sept. 22 and started feeling ill the next morning. His health took a turn for the worse two days […]
FDA, CDC Green Light Pfizer’s Experimental COVID Biologic for Children 5 to 11 Years Old
One Oct 29, 2021, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the experimental messenger RNA (mRNA) Pfizer/BioNTech COVID-19 biologic BNT162b2 for children five to 11 years old. The FDA’s decision, which is based on a clinical trial earlier this year involving 2,268 kindergartners and elementary school-aged kids and an […]